There are over 200 distinct types of cancer, and that number climbs into the hundreds more when you factor in molecular subtypes revealed by genetic testing. The National Cancer Institute maintains a comprehensive A to Z list of cancer types, and from a tissue-level perspective, the NCI’s training materials describe “hundreds of different cancers.” The exact count depends on how you slice it: by the organ where cancer starts, by the type of cell involved, or by the genetic profile of the tumor itself.
The Six Major Categories
Every cancer falls into one of six broad groups, classified by the type of cell it originates from.
- Carcinoma: Cancer of the cells lining your organs, skin, and glands. This is by far the most common category, accounting for 80 to 90 percent of all cancer cases. Breast, lung, colon, and prostate cancers are all carcinomas.
- Sarcoma: Cancer that starts in connective and supportive tissues like bone, cartilage, muscle, fat, and tendons. These are relatively rare compared to carcinomas.
- Leukemia: Cancer of the bone marrow, where blood cells are produced. Often called “liquid cancer” or “blood cancer,” leukemia typically involves the overproduction of immature white blood cells.
- Lymphoma: Cancer that develops in the lymphatic system, the network of nodes and vessels that produces infection-fighting white blood cells. Unlike leukemia, lymphomas form solid tumors in lymph nodes or organs like the spleen and tonsils.
- Myeloma: Cancer of the plasma cells in bone marrow. Plasma cells normally produce proteins found in your blood, and myeloma disrupts that process.
- Mixed types: Some cancers contain more than one cell type, sometimes even from different categories. Carcinosarcoma, for instance, has features of both carcinoma and sarcoma.
Genetic Testing Has Multiplied the Count
Cancers were traditionally classified by where they started in the body and what the cells looked like under a microscope. That system still matters, but large-scale genome projects like The Cancer Genome Atlas (TCGA) have revealed that cancers sharing the same organ and appearance can behave very differently at the molecular level. Two breast cancers that look identical under a microscope may have completely different genetic drivers, respond to different treatments, and carry different prognoses.
The TCGA project alone identified 106 molecular subtypes across 26 different cancer types. That kind of granularity is why your oncologist might order genomic testing on a tumor, not just to confirm the cancer type but to identify which subtype it is and which treatments are most likely to work. When you include all of these molecular distinctions, the number of meaningfully different “kinds” of cancer stretches well beyond what any single list can capture.
The Most Common Types Worldwide
A small number of cancers account for a large share of all diagnoses. Based on 2022 global estimates from the World Health Organization, the five most frequently diagnosed cancers were:
- Lung cancer: 2.5 million new cases, representing 12.4% of all cancers diagnosed that year
- Female breast cancer: 2.3 million cases (11.6%)
- Colorectal cancer: 1.9 million cases (9.6%)
- Prostate cancer: 1.5 million cases (7.3%)
- Stomach cancer: 970,000 cases (4.9%)
Together, just these five types made up nearly half of all new cancer cases globally. Cervical cancer ranked eighth, with about 661,000 new cases.
Rare Cancers Are Surprisingly Numerous
While a handful of cancer types dominate the statistics, the long tail of rare cancers is enormous. The Surveillance of Rare Cancer in Europe project defines a rare cancer as any type with fewer than 6 new cases per 100,000 people each year. By that definition, the SEER program (the U.S. cancer surveillance system) identifies roughly 300 distinct rare cancer types. Individually, each is uncommon. Collectively, rare cancers affect a significant number of people and often present unique challenges because fewer patients means less research and fewer established treatment protocols.
Childhood Cancers Are a Different Set
The cancers that affect children look very different from the ones that dominate adult statistics. While adult cancers most often strike the lungs, breast, colon, and prostate, childhood cancers tend to affect blood cells, the lymphatic system, the brain, bones, and the adrenal glands. The single most common cancer in children is acute lymphoblastic leukemia.
The causes differ too. Adult cancers often develop over decades, influenced by lifestyle factors like smoking, diet, and sun exposure. Childhood cancers are not linked to lifestyle choices. They arise from changes in cells that sometimes happen very early in development, even before birth.
One significant difference works in children’s favor: the chance of recovery is much higher. Most children with cancer can be cured. Their cancer cells tend to respond better to treatment, and children generally tolerate more intensive chemotherapy with faster recovery times than adults experience.
Why the Number Keeps Growing
The total count of cancer types is not fixed. Every advance in diagnostic technology reveals finer distinctions. What was once “lung cancer” is now subdivided by cell type (small cell vs. non-small cell), then further split by specific genetic mutations that determine which targeted therapies will work. A cancer that looked like one disease 20 years ago may now be understood as five or six distinct diseases that happen to start in the same organ.
So while the practical answer is that there are roughly 200 or more recognized cancer types, the functionally distinct number, once you account for molecular subtypes, is considerably larger and still expanding. What matters most is that these finer classifications allow for more precise treatment. Knowing exactly which kind of cancer you’re dealing with, down to its genetic signature, is what makes modern oncology increasingly effective at matching patients to therapies that target their specific disease.